Legend Biotech Balance Sheet
NASDAQ: LEGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Legend Biotech financial position
At the end of fiscal 2025, Legend Biotech reported total assets of $1.73 billion, up 3.8% from a year earlier against total liabilities of $731.6 million. Shareholders' equity stood at $1.00 billion, or 57.8% of assets. The company held $901.9 million in cash and equivalents against $319.1 million of debt, a net cash position of $582.8 million.
The current ratio (current assets divided by current liabilities) was 1.96, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.32.
Summary generated from market data by MetaCap's automated system. Methodology
Legend Biotech balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 901.90M | 286.70M | 1.28B | 786.00M | 688.94M | 455.69M | 83.36M | 210.17M |
| Inventory | 32.00M | 23.90M | 19.43M | 10.35M | 1.75M | 1.80M | 1.16M | — |
| Total Current Assets | 1.25B | 1.28B | 1.50B | 1.10B | 949.85M | 593.94M | 207.10M | — |
| Property, Plant & Equipment | 116.30M | 99.30M | 108.80M | 105.17M | 102.51M | 72.34M | 45.19M | 28.16M |
| Intangible Assets | 1.90M | 2.20M | 4.06M | 3.41M | 4.68M | 2.85M | 519.00K | — |
| Total Assets | 1.73B | 1.67B | 1.85B | 1.33B | 1.12B | 722.09M | 287.71M | — |
| Short-Term Debt | 319.10M | 0 | — | — | — | — | — | — |
| Total Current Liabilities | 636.40M | 277.70M | 216.42M | 297.79M | 229.20M | 115.57M | 127.76M | — |
| Long-Term Debt | 0 | 301.20M | 281.33M | 260.93M | 120.46M | — | — | — |
| Total Liabilities | 731.60M | 629.60M | 597.24M | 586.65M | 353.52M | 124.32M | 410.58M | — |
| Shareholders' Equity | 1.00B | 1.04B | 1.25B | 744.31M | 765.94M | 597.77M | -122.87M | 252.91M |
| Retained Earnings | — | — | — | — | 471.20M | 280.20M | -122.90M | — |
| Total Debt | 319.10M | 301.20M | 281.33M | 260.93M | 120.46M | — | — | — |
| Net Cash (Debt) | 582.80M | -14.50M | 996.37M | 525.07M | 568.48M | 455.69M | 83.36M | 210.17M |
This table shows 8 annual periods of Legend Biotech's balance sheet, from FY 2025 back to FY 2018, across 14 line items including cash & equivalents, inventory, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow LEGN's reporting calendar. What is a balance sheet?